Wet Age-Related Macular Degeneration

The potential of artificial intelligence for the diagnosis and management of age-related macular degeneration is vast.

The link between nutrition and ocular health became apparent in the early 1990s as epidemiologists and ophthalmologists uncovered dietary patterns in patients with AMD.

Healio spoke with Yasha Modi, MD, to discuss treatment options available to manage patients with geographic atrophy and more.

With emerging treatment options and technological advances that make detection and monitoring more precise, timely and easier, wet age-related macular degeneration continues to be a vibrant area of research and innovation.

Anti-VEGF agents have transformed retinal disease management.

SAN DIEGO — Patients whose conversion to wet age-related macular degeneration was detected early with ForeseeHome monitoring maintained their vision long term, Mohammad Rafieetary, OD, FAAO, said at Academy 2022.

Anthony DeWilde OD, FAAO, director of the tele-eye imaging program at VA Kansas City Health Care, discusses a presentation at Academy that focused on geographic atrophy in age-related macular degeneration.

In a video interview with Healio, Anthony DeWilde OD, FAAO, director of the tele-eye imaging program at VA Kansas City Health Care, discusses his presentation at Academy on anti-VEGF therapy for various ocular conditions.

CHICAGO — In this video from Eyecelerator@AAO, Opthea CEO Megan Baldwin, PhD, discusses updates for OPT-302, a therapy targeting a new mechanism of action for the treatment of wet age-related macular degeneration.

In this video, Manjot K. Gill, MD, professor of ophthalmology and medical education at Northwestern Feinberg School of Medicine, discusses how treatment approaches differ when treating wet AMD and dry AMD.